RYGB与袖状胃切除术对2型糖尿病缓解的比较:荟萃分析
RYGB在术后1年宽泛和严格缓解标准上均优于SG,5年时仅宽泛标准有优势,其他时间点无差异。
要点
- RYGB在术后1年糖尿病缓解率优于SG(宽泛标准RR=1.34,严格标准RR=1.22)。
- 术后5年RYGB仅在宽泛缓解标准上优于SG(RR=1.18),严格标准无差异。
- 术后3年两组在宽泛和严格缓解标准上均无显著差异。
核心结论
- RYGB相比SG仅在短期(1年)对2型糖尿病缓解更有利,长期差异是否持续或消失尚不明确。
主要发现
- 总体宽泛和严格缓解率在1年分别为73%和53%,3年为60%和48%,5年为51%和43%。
- 术后1年RYGB相比SG的宽泛缓解RR=1.34,严格缓解RR=1.22。
- 术后5年RYGB相比SG的宽泛缓解RR=1.18,严格缓解无显著差异。
- 术后3年两组宽泛和严格缓解均无显著差异。
关键数值与推荐
- 宽泛和严格T2D缓解标准由研究者定义以确保统一性。
- 术后1年RYGB vs SG宽泛缓解RR=1.34,严格缓解RR=1.22。
- 术后5年RYGB vs SG宽泛缓解RR=1.18。
临床怎么用
- 对于2型糖尿病患者,选择RYGB可能在短期(1年)获得更高的缓解率,但长期优势不明确。
- 临床决策应综合考虑短期缓解获益与长期不确定性,个体化选择术式。
局限性
- 现有证据无法明确RYGB与SG在糖尿病缓解上的差异是否长期持续或消失。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG) are the bariatric procedures most commonly used for the management of obesity. Whether one or the other is associated with a higher chance of remission of type 2 diabetes (T2D) is unclear. OBJECTIVE: This work aims to compare the efficacy of RYGB and SG for T2D remission at 1, 3, and 5 years after surgery. DATA SOURCES: Four databases were searched until January 2020. STUDY SELECTION: Randomized controlled studies with at least 12 months of follow-up of patients with T2D allocated to RYGB or SG were selected. DATA EXTRACTION: To ensure uniformity, broad and narrow criteria for T2D remission were defined. The number of patients achieving remission of T2D at each assessment was extracted. Data were pooled using a random-effects model. DATA SYNTHESIS: Ten studies were included, evaluating 778 patients. The overall prevalence of achievement of broad and narrow criteria for T2D remission was 73% and 53% at the 1-year, 60% and 48% at the 3-year, and 51% and 43% at the 5-year assessment. Compared to SG, RYGB was associated with a higher chance of achieving broad and narrow criteria for remission at 1 year after surgery (risk ratio [RR] = 1.34 vs RR = 1.22) and broad criteria for remission at 5 years (RR = 1.18). No other differences were found. CONCLUSIONS: The present meta-analysis suggests a more favorable effect of RYGB than SG on achieving T2D remission in the short-term only, although the evidence currently available does not clarify whether differences in this outcome are confirmed long term or fade thereafter.
引用
- Castellana M, Procino F, Biacchi E, et al. Roux-en-Y Gastric Bypass vs Sleeve Gastrectomy for Remission of Type 2 Diabetes. J Clin Endocrinol Metab. 2021. PMID: 33051679. doi:10.1210/clinem/dgaa737
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。